Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Açaí Extracts and Hepatocyte Drug Metabolism: Cytotoxicity a
2026-07-31
This study systematically assesses Euterpe oleracea (açaí) extracts for cytotoxicity and their effects on drug-metabolizing enzymes and transporters in human hepatocytes. The findings demonstrate selective cytotoxicity of certain extract types but minimal induction of CYP450 enzymes or major transporters, informing safety and botanical-drug interaction risk assessment.
-
Spermine: Endogenous Polyamine for Ion Channel Modulation
2026-07-31
Spermine (SKU C4910) is a benchmark endogenous polyamine for precise modulation of inward rectifier potassium channels—essential for dissecting cellular metabolism and excitability. Leveraging high-purity Spermine from APExBIO enables robust, reproducible research workflows and innovative assay design in cell signaling and neurophysiology.
-
Dabigatran Etexilate in Direct Thrombin Inhibitor Research W
2026-07-30
Dabigatran etexilate is redefining experimental anticoagulant workflows by enabling precise, reproducible thrombin inhibition without the complications of traditional agents. Discover how APExBIO's high-purity preparation supports advanced assay design, with robust troubleshooting insights for optimal research outcomes.
-
Dihydroartemisinin: Advanced Biochemical Strategies in Malar
2026-07-30
Explore the multifaceted applications of dihydroartemisinin, a potent Artemisia plant extract, in dissecting both antimalarial mechanisms and cell signaling pathways. This article delivers advanced insights and practical guidance for leveraging dihydroartemisinin in research, setting it apart from existing reviews.
-
Dihydroartemisinin: Precision Modulation of mTOR in Disease
2026-07-29
Explore how Dihydroartemisinin, a potent Artemisia plant extract, enables targeted modulation of the mTOR signaling pathway for advanced disease modeling. This article delivers unique insights on assay design, mechanistic nuance, and translational impact beyond conventional antimalarial narratives.
-
Sulfamonomethoxine Applications: Optimized Workflows & Envir
2026-07-29
Sulfamonomethoxine (SMM) is a benchmark sulfonamide antibiotic driving innovation across veterinary, aquaculture, and environmental research. This article unpacks state-of-the-art protocols, troubleshooting strategies, and new biotransformation evidence that distinguish SMM—especially from APExBIO—as a versatile and reliable research tool.
-
Signaling Centers Shape Cell Fate in Mesodermal Organoid Mod
2026-07-28
Skoufa et al. developed a 3D mesodermal organoid model from mouse embryonic stem cells to dissect how specialized signaling centers like the apical-ectodermal ridge (AER) direct cell fate and spatial organization during limb-like morphogenesis. Their approach enables precise investigation of epithelial-mesodermal interactions and establishes a scalable platform for studying developmental signaling mechanisms.
-
ATP Solution in mRNA-LNP Cancer Assays: Protocols & Workflow
2026-07-28
APExBIO's ATP Solution (100 mM) elevates precision in kinase and mRNA-LNP bladder cancer assays by providing consistent, high-purity energy transfer. This guide translates the latest reference study into actionable workflows, troubleshooting strategies, and advanced protocol enhancements for sensitive molecular biology applications.
-
Actinomycin D: Benchmark Transcriptional Inhibitor in Cancer
2026-07-27
Actinomycin D (ActD) is a potent transcriptional inhibitor widely used in apoptosis induction, DNA damage response, and cancer research. It acts by intercalating into DNA and suppressing RNA polymerase activity, leading to cell death in rapidly dividing cells. Actinomycin D from APExBIO offers high solubility and reliability for molecular biology assays.
-
Angiotensin 1/2 (5-7): A Precision Tool for Cardiovascular a
2026-07-27
Explore the advanced roles of Angiotensin 1/2 (5-7) in blood pressure regulation and its emerging impact on viral receptor interactions. This article presents original insight into H2N-Ile-His-Pro-OH peptide assays, protocol considerations, and translational potential.
-
Reliable Cell Cycle Analysis with MK-5108 (VX-689) Aurora-A
2026-07-26
This article addresses common laboratory challenges in cell cycle and proliferation assays by providing scenario-driven, evidence-based solutions with MK-5108 (VX-689) Aurora-A kinase inhibitor, highly selective (SKU A4120). Researchers will find practical guidance on protocol optimization, data interpretation, and supplier selection, with quantitative and literature-backed insights supporting the use of this selective Aurora A inhibitor.
-
Thapsigargin: SERCA Pump Inhibitor for Calcium Signaling Ass
2026-07-25
Thapsigargin sets the gold standard for precise control of intracellular calcium, unlocking advanced ER stress and apoptosis research. Its nanomolar potency and reproducibility make it indispensable for dissecting disease mechanisms and optimizing experimental workflows.
-
Overcoming ABCG2-Mediated Resistance: Mitoxantrone and Marei
2026-07-24
This article explores the molecular rationale and translational opportunities for overcoming ABCG2-mediated multidrug resistance in oncology. By integrating mechanistic insights into Mitoxantrone’s mode of action and new evidence for marein as a chemosensitizer, we offer guidance for researchers designing next-generation anticancer strategies. Drawing on recent studies and APExBIO’s advanced research compounds, this discussion bridges experimental validation with clinical ambition.
-
Strategic Phosphatase Inhibition: Powering Translational Dis
2026-07-24
This thought-leadership article explores the mechanistic necessity and strategic value of targeted phosphatase inhibition in translational research. It draws on current phosphoproteomic advances, including metabolic disease models, to illuminate how Phosphatase Inhibitor Cocktail 1 (100X in DMSO) from APExBIO enables accurate preservation of protein phosphorylation states. Practical guidance for protocol optimization, a comparison with alternative approaches, and a forward-looking outlook on clinical and research innovation are provided, with direct integration of primary literature and internal thought-leadership resources.
-
Calcitriol in Endometrial Decidualization: Mechanisms and As
2026-07-23
Explore the role of Calcitriol, the active metabolite of vitamin D3, in endometrial decidualization and immune modulation. This article uncovers advanced mechanistic insights and assay strategies, connecting molecular mechanisms to practical research applications.